Prevention of neural tube defects: A cross-sectional study of the uptake of folic acid supplementation in nearly half a million women

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Bestwick, Jonathan P ^a   Huttly, Wayne J ^a   Morris, Joan K ^a   Wald, Nicholas J ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

ADOLESCENT; AFRICAN CARIBBEAN; AGE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DOWN SYNDROME; ETHNIC DIFFERENCE; ETHNIC GROUP; FEMALE; FERTILIZATION IN VITRO; FIRST TRIMESTER PREGNANCY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; NEURAL TUBE DEFECT; NON INSULIN DEPENDENT DIABETES MELLITUS; ORIENTAL; PREGNANCY; SECOND TRIMESTER PREGNANCY; SOUTH ASIAN; VITAMIN SUPPLEMENTATION;

CONTINENTAL POPULATION GROUPS; CROSS-SECTIONAL STUDIES; DIETARY SUPPLEMENTS; ENGLAND; FEMALE; FOLIC ACID; HUMANS; MULTIVARIATE ANALYSIS; NEURAL TUBE DEFECTS; PREGNANCY;

EID: 84897786389     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089354     Document Type: Article

References (16)

1. MRC Vitamin Study Research Group (1991) Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338: 131-137.
2. Flour Fortification Inititative. Global Progress. Available: http://www.ffinetwork.org/global-progress/. Accessed 9 October 2013.
3. Honein MA, Paulozzi LJ, Matthes TJ, Erickson JD, Wong LY (2001) Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 285: 2981-6. (Pubitemid 32550116)
4. Lopez-Camelo JS, Orioli IM, da Graca Dutra M, Nazer-Herrera J, Rivera N, et al. (2005) Reduction of birth prevalence rate of neural tube defects after folic acid fortification in Chile. Am J Med Genet A 135: 120-5. (Pubitemid 40769959)
5. De Wals P, Tairou F, Van Allen MI, Uh SH, Lowry RB, et al. (2007) Reduction in neural-tube defects after folic acid fortification in Canada. New Engl J Med 357: 135-42. (Pubitemid 47057731)
6. Expert Advisory Group (1992) Folic acid and the prevention of neural tube defects. London: Department of Health.
7. Huttly WJ, Wald NJ, Walters JC (1999) Folic acid supplementation before pregnancy remains inadequate. BMJ 319: 1499.1.
8. Zou G (2004) A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 159: 702-6.
9. Ray JG, Singh G, Burrows RF (2004) Evidence for suboptimal use of periconceptional folic acid supplements globally. BJOG 111: 399-408. (Pubitemid 38621868)
10. NHS (2012) NHS Fetal Anomaly Screening Programme Annual report 2011-2012. Available: fetalanomaly.screening.nhs.uk/getdata.php?id=11702. Accessed 28 January 2014.
11. Oakley GP Jr (1998) Folic-acid-preventable spina bifida and anencephaly. Bull World Health Organ (suppl 2): 116-7.
12. Therapontos C, Erskine L, Gardner ER, Figg WD, Vargesson N (2009) Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation. Proc Natl Acad Sci 106: 8573-8.
13. Bayston R, Russell A, Wald NJ, Hoffbrand AV (2007) Folic acid fortification and cancer risk. Lancet 370: 2004. (Pubitemid 350236334)
14. Bayston R, Russell A, Wald NJ, Hoffbrand AV (2007) Folic acid fortification and cancer risk. Lancet 371: 1335-6.
15. Vollset SE, Clarke R, Lewington S, Ebbing M, Halsey J, et al (2013) Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50000 individuals. Lancet 381: 1029-36.
16. Wald NJ, Law MR, Morris JK, Wald DS (2001) Quantifying the effect of folic acid. Lancet 358: 2069-73. (Pubitemid 34084836)